Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

LifeMD (LFMD) announces the launch by its Rex MD men’s health brand of TestoRx, a new direct-to-consumer men’s hormone ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2024 after the close ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces the launch by its Rex MD men’s health brand of TestoRx, a new direct-to-consumer men’s hormone therapy ...

PharmaTher Holdings Ltd. (the "Company” or "PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a ...

Buy and Sell Signals for Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP that help investors manage ...

Analyst David Larsen from BTIG maintained a Buy rating on LifeMD (LFMD – Research Report) and keeping the price target at $12.00. David ...

B. Riley Securities has recently resumed LifeMD Inc (LFMD) stock to Buy rating, as announced on August 23, 2024, according to Finviz. Earlier, on June 5, 2024, KeyBanc Capital Markets had initiated ...

Revised Full-Year Adjusted EBITDA Guidance: $13 million to $15 million, down from $18 million to $22 million. LifeMD Inc (NASDAQ:LFMD) reported a 67% year-over-year revenue growth in its core ...

Despite a significant revenue decline, Medifast Inc (MED) is strategically pivoting to capture a larger market with new ...

B.Riley has maintained a Buy rating and an $11.00 price target for LifeMD Inc (NASDAQ: LFMD), following news from WeightWatchers about their new compounded semaglutide offering, which is similar to ...